LABORATORIO FARMAC.ERFO Tangible Net Worth Ratio
LABORATORIO FARMAC.ERFO tangible net worth ratio. LABORATORIO FARMAC.ERFO (RK7) has a Tangible Net Worth Ratio of 54.4% as of June 2024. This metric is calculated by deducting intangible assets (€3.44 Million) from net assets (€7.54 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See RK7 equity to assets ratio to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of LABORATORIO FARMAC.ERFO (2021–2023)
Tangible net worth ratio of LABORATORIO FARMAC.ERFO from 2021 to 2023. This chart shows how LABORATORIO FARMAC.ERFO's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2023. As of June 2024, the ratio stands at 54.4%, reflecting net assets of €7.54 Million with intangible assets of €3.44 Million EUR. See RK7 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
LABORATORIO FARMAC.ERFO Tangible Net Worth Ratio by Year (2021–2023)
LABORATORIO FARMAC.ERFO tangible net worth ratio by year from 2021 to 2023. The table below presents the year-by-year Tangible Net Worth Ratio for LABORATORIO FARMAC.ERFO from 2021 to 2023, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of LABORATORIO FARMAC.ERFO.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 54.7% | €7.88 Million | €3.57 Million | €10.15 Million | ▲ +4.8 pp |
| 2021 | 49.9% | €4.73 Million | €2.37 Million | €6.93 Million | — |